Literature DB >> 9579824

The promoting effect of tumour necrosis factor alpha in radiation-induced cell transformation.

R F Guo1, Y F Gong.   

Abstract

The ability of tumour necrosis factor alpha (TNF-alpha), a potent endogenous inflammatory agent, to promote malignant transformation of Syrian hamster embryo cells (SHE) initiated by a 0.5-Gy dose of alpha-particles was investigated. Opsonized zymosan particles, which were phagocytosed by a human macrophage-like cell line, triggered TNF-alpha production from U937 cells. This cell supernatant could significantly increase the transformation frequency (TF) of primary SHE cells previously irradiated by a 0.5-Gy dose of alpha-particles. The TF decreased significantly if monoclonal antibody against TNF-alpha was added to the supernatant. Similarly, recombinant human TNF-alpha (rhTNF-alpha) increased the TF of alpha-irradiated primary SHE cells to an even greater extent. Addition of TNF-alpha to subcultures of irradiated SHE cells permitted the continuous propagation of these primary cells. In contrast, both TNF-alpha-treated control and alpha-irradiated cells without subsequent TNF-alpha treatment senesced after 7-15 passages. Irradiated SHE cells treated continuously with TNF-alpha could be subcultured over 40 passages and produced fibrosarcomas upon inoculation into nude mice. Our results provide the first evidence that TNF-alpha released by activated macrophages may contribute to the process of malignant transformation initiated by low-dose alpha-particles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579824      PMCID: PMC2150167          DOI: 10.1038/bjc.1998.204

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Transformation of mammalian cells in vitro by low doses of X-rays.

Authors:  C Borek; E J Hall
Journal:  Nature       Date:  1973-06-22       Impact factor: 49.962

2.  Stopping power and range of alpha particles.

Authors:  P J Walsh
Journal:  Health Phys       Date:  1970-08       Impact factor: 1.316

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Quantitative in vitro transformation of Syrian golden hamster embryo cells with the use of frozen stored cells.

Authors:  J A DiPaolo
Journal:  J Natl Cancer Inst       Date:  1980-06       Impact factor: 13.506

5.  Active oxygen acts as a promoter of transformation in mouse embryo C3H/10T1/2/C18 fibroblasts.

Authors:  R Zimmerman; P Cerutti
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.

Authors:  H Engelmann; H Holtmann; C Brakebusch; Y S Avni; I Sarov; Y Nophar; E Hadas; O Leitner; D Wallach
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

7.  A new process of cancer prevention mediated through inhibition of tumor necrosis factor alpha expression.

Authors:  M Suganuma; S Okabe; E Sueoka; N Iida; A Komori; S J Kim; H Fujiki
Journal:  Cancer Res       Date:  1996-08-15       Impact factor: 12.701

8.  Transformation of mammalian cells by alpha particles.

Authors:  E L Lloyd; M A Gemmell; C B Henning; D S Gemmell; B J Zabransky
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1979-11

9.  Systemic macrophage stimulation in rats with silicosis: enhanced release of tumor necrosis factor-alpha from alveolar and peritoneal macrophages.

Authors:  C Mohr; D Gemsa; C Graebner; D R Hemenway; K O Leslie; P M Absher; G S Davis
Journal:  Am J Respir Cell Mol Biol       Date:  1991-10       Impact factor: 6.914

10.  Modifiers of free radicals inhibit in vitro the oncogenic actions of x-rays, bleomycin, and the tumor promoter 12-O-tetradecanoylphorbol 13-acetate.

Authors:  C Borek; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.